ERBB2 and neoplasm: Likewise, an sdAb that targeted Domain IV of HER2, 5F7, exhibited excellent tumor targeting and internalizing properties9,11,22,26–28 that appeared advantageous compared to 2Rs15d28,29, although published head-to-head comparisons are lacking.